Caregiver Burden in Growth Hormone Deficiency: A Targeted Review

Author(s)

Amini F1, Alsawady M2, Borecka O3, Bottomley C1
1Vitaccess, Oxford, Oxford, UK, 2Vitaccess, Richmond, UK, 3Vitaccess, Oxford, OXF, UK

OBJECTIVES: Growth hormone deficiency (GHD) results in growth retardation and maturation delays, and treatment often involves daily hormone injections. Considering the increasing interest in disease impact on those closest to the patient, this review aimed to identify literature assessing the burden experienced by caregivers of people with GHD.

METHODS: A targeted literature review was performed using the PubMed and Google Scholar databases. The search strategy included disease-specific keywords (i.e., “growth hormone deficiency”, “short stature”, and/or “recombinant human growth hormone therapy”), along with the search terms “caregiver” and/or “carer”.

RESULTS: Seven research papers exploring the impact of GHD on caregivers across the US and Europe were identified, with methodologies ranging from qualitative interviews (two studies) to quantitative surveys (four studies) and a mixed-methods study.

Five studies described the burden of caregiving in terms of an impact on daily life and activities. Common themes included an impact on travel (including family travel and travel planning/logistics), social life, and the burden associated with injection preparation, administration, and storage. One study found that caring for someone receiving weekly treatments resulted in lower burden and life interference than daily treatments.

An additional emergent theme (described in four studies) was the emotional impact of caregiving responsibilities. Qualitative research described burden in terms of worry, sadness, guilt, and frustration, as well as difficulty in managing negative reactions from patients and anxiety concerning administering injections. This impact extended to reduced mental wellbeing and self-efficacy. One quantitative study associated caregiving stress with disease severity, which in turn impacted caregivers’ overall quality of life.

CONCLUSIONS: This review identified literature describing caregiver burden in GHD in terms of an impact on daily life and activities and emotional wellbeing. Inclusion of the caregiver perspective in healthcare decision-making is essential to capture the full picture of the burden of GHD and its treatment.

Conference/Value in Health Info

2023-11, ISPOR Europe 2023, Copenhagen, Denmark

Value in Health, Volume 26, Issue 11, S2 (December 2023)

Code

SA25

Topic

Study Approaches

Topic Subcategory

Literature Review & Synthesis

Disease

No Additional Disease & Conditions/Specialized Treatment Areas, Rare & Orphan Diseases

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×